Journal
CELL METABOLISM
Volume 15, Issue 5, Pages 585-594Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2012.04.002
Keywords
-
Categories
Funding
- National Institutes of Health [DK081456]
Ask authors/readers for more resources
The recent implementation of genomic and lipidomic approaches has produced a large body of evidence implicating the sphingolipid ceramide in a diverse range of physiological processes and as a critical modulator of cellular stress. In this review, we discuss from a historical perspective the most important discoveries produced over the last decade supporting a role for ceramide and its metabolites in the pathogenesis of insulin resistance and other obesity-associated metabolic diseases. Moreover, we describe how a ceramide-centric view of insulin resistance might be reconciled in the context of other prominent models of nutrient-induced insulin resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available